USRE43527EExpiredUtility
Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
Individually held — no corporate assignee on recordPriority: May 6, 2004Filed: Nov 25, 2008Granted: Jul 17, 2012
Est. expiryMay 6, 2024(expired)· nominal 20-yr term from priority
Inventors:Shane M. Popp
G05B 23/0224G05B 23/0235G05B 2219/11G05B 2223/02G05B 2219/1112G06Q 10/06
74
PatentIndex Score
3
Cited by
435
References
6
Claims
Abstract
Methods, systems, and software program for validation of pharmaceutical manufacturing processes and quality assurance process are described and disclosed herein. Consequently, the methods provide a means to perform validation on an integrated level whereby the quality control unit can ensure data and product integrity and minimize cost.
Claims
exact text as granted — not AI-modified1. A method for monitoring a pharmaceutical manufacturing process using at least a dry heat sterilizer, said method comprising:
a) deriving an algorithm implemented in computer executable instructions that performs data analysis on said pharmaceutical manufacturing process using at least a dry heat sterilizer;
b) performing “logic analysis” on said algorithm;
c) performing “software safety code analysis” on said algorithm;
d) performing “software safety design analysis” on said algorithm;
e) performing “software safety requirements analysis” on said algorithm;
f) performing “software safety test analysis” on said algorithm;
g) integrating the said algorithm into a pharmaceutical manufacturing process whereby actual monitoring of the manufacturing process is attained.
2. The method of claim 1 , wherein the “data analysis” is selected from the group consisting of “boundary value analysis”, “block check”, “branch analysis”, “control flow analysis”, “failure analysis”, and “path analysis”.
3. The method of claim 1 , wherein the pharmaceutical manufacturing occurs in a clinical manufacturing process.
4. The method of claim 1 , wherein the pharmaceutical manufacturing occurs in a post-clinical commercial manufacturing process.
5. A computer memory having computer executable instructions to perform the method according to claim 1 .
6. A kit comprising the computer memory having computer executable instructions of claim 5 .Join the waitlist — get patent alerts
Track USRE43527E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.